Bio-Techne (TECH) Cash from Financing Activities (2009 - 2026)

Bio-Techne's Cash from Financing Activities history runs 18 years deep, the most recent figure standing at -$42.7 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities rose 37.22% year-over-year to -$42.7 million; the TTM figure through Mar 2026 stood at -$226.4 million (down 1.26% YoY), while the FY2025 annual figure was -$253.9 million, down 107.44% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at -$42.7 million, up from -$49.0 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $150.8 million in Q1 2023, with the low at -$90.5 million in Q2 2025.
• The 5-year median for Cash from Financing Activities is -$52.4 million (2024), against an average of -$37.6 million.
• The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities soared 324.84% in 2023, then plunged 282.02% in 2025.
• Bio-Techne's Cash from Financing Activities stood at -$72.2 million in 2022, then fell by 12.75% to -$81.4 million in 2023, then fell by 3.0% to -$83.8 million in 2024, then jumped by 41.57% to -$49.0 million in 2025, then rose by 12.8% to -$42.7 million in 2026.
• Business Quant data shows TECH's Cash from Financing Activities at -$42.7 million in Q1 2026, -$49.0 million in Q4 2025, and -$44.2 million in Q3 2025.